Regenxbio Inc (RGNX)

Healthcare Pharmaceuticals & Medical Research Biotechnology & Medical Research

Track Share on 𝕏

Stock chart
Ticker: RGNX Exchange: NSM


Subscribe to get access to the transaction volume chart and in-chart transaction details
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale
Past 90 days
 
Value bought
 
Value sold
 
Net insiders buying
 
Trades (buy and sell)
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PS: Planned sale, O: Option / Other
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Total value Details
2019-09-23 2019-09-19 PS Planned sale

Mills Kenneth T.

President and CEO
7,773 -3.1%
39.91
310,220 USD 		7,773 -3.1% 39.91 310,220 USD
2019-09-23 2019-09-19 PS Planned sale

Mills Kenneth T.

President and CEO
2,227 -0.9%
39.19
87,276 USD 		2,227 -0.9% 39.19 87,276 USD
2019-09-16 2019-09-12 PS Planned sale

Christmas Patrick J.

SVP, General Counsel
5,486 -68.1%
42.00
230,412 USD 		5,486 -68.1% 42.00 230,412 USD
2019-08-21 2019-08-19 PS Planned sale

Mills Kenneth T.

President and CEO
376 -0.2%
37.92
14,258 USD 		376 -0.2% 37.92 14,258 USD
2019-08-21 2019-08-19 PS Planned sale

Mills Kenneth T.

President and CEO
14,624 -5.6%
37.54
548,985 USD 		14,624 -5.6% 37.54 548,985 USD
2019-07-23 2019-07-19 PS Planned sale

Mills Kenneth T.

President and CEO
2,300 -0.9%
49.97
114,931 USD 		2,300 -0.9% 49.97 114,931 USD
2019-07-23 2019-07-19 PS Planned sale

Mills Kenneth T.

President and CEO
12,700 -4.9%
49.40
627,380 USD 		12,700 -4.9% 49.40 627,380 USD
2019-07-22 2019-07-19 PS Planned sale

Christmas Patrick J.

SVP, General Counsel
4,900 -61.6%
50.03
245,147 USD 		4,900 -61.6% 50.03 245,147 USD
2019-07-22 2019-07-18 PS Planned sale

Christmas Patrick J.

SVP, General Counsel
100 -3.2%
50.00
5,000 USD 		100 -3.2% 50.00 5,000 USD
2019-06-21 2019-06-19 PS Planned sale

Mills Kenneth T.

President and CEO
4,120 -1.6%
53.25
219,390 USD 		4,120 -1.6% 53.25 219,390 USD
2019-06-21 2019-06-19 PS Planned sale

Mills Kenneth T.

President and CEO
10,880 -4.2%
52.27
568,698 USD 		10,880 -4.2% 52.27 568,698 USD
2019-06-20 2019-06-18 PS Planned sale

Christmas Patrick J.

SVP, General Counsel
100 -3.2%
54.75
5,475 USD 		100 -3.2% 54.75 5,475 USD
2019-06-20 2019-06-18 PS Planned sale

Christmas Patrick J.

SVP, General Counsel
1,934 -38.4%
53.29
103,063 USD 		1,934 -38.4% 53.29 103,063 USD
2019-06-20 2019-06-18 PS Planned sale

Christmas Patrick J.

SVP, General Counsel
2,966 -37.0%
52.74
156,427 USD 		2,966 -37.0% 52.74 156,427 USD
2019-05-30 2019-05-28 PS Planned sale

Simpson Curran

SVP, Product Development & CTO
18,000 -31.3%
50.00
900,000 USD 		18,000 -31.3% 50.00 900,000 USD
2019-05-22 2019-05-20 PS Planned sale

Mills Kenneth T.

President and CEO
300 -0.1%
43.99
13,197 USD 		300 -0.1% 43.99 13,197 USD
2019-05-22 2019-05-20 PS Planned sale

Mills Kenneth T.

President and CEO
10,559 -4.1%
43.32
457,416 USD 		10,559 -4.1% 43.32 457,416 USD
2019-05-22 2019-05-20 PS Planned sale

Mills Kenneth T.

President and CEO
4,141 -1.6%
42.08
174,253 USD 		4,141 -1.6% 42.08 174,253 USD
2019-04-24 2019-04-22 PS Planned sale

Mills Kenneth T.

President and CEO
100 -0.0%
53.05
5,305 USD 		100 -0.0% 53.05 5,305 USD
2019-04-24 2019-04-22 PS Planned sale

Mills Kenneth T.

President and CEO
1,300 -0.5%
52.33
68,029 USD 		1,300 -0.5% 52.33 68,029 USD
2019-04-24 2019-04-22 PS Planned sale

Mills Kenneth T.

President and CEO
3,270 -1.3%
51.07
166,999 USD 		3,270 -1.3% 51.07 166,999 USD
2019-04-24 2019-04-22 PS Planned sale

Mills Kenneth T.

President and CEO
6,929 -2.7%
50.31
348,598 USD 		6,929 -2.7% 50.31 348,598 USD
2019-04-24 2019-04-22 PS Planned sale

Mills Kenneth T.

President and CEO
3,401 -1.3%
49.29
167,635 USD 		3,401 -1.3% 49.29 167,635 USD
2019-04-22 2019-04-18 PS Planned sale

Christmas Patrick J.

SVP, General Counsel
100 -3.2%
55.50
5,550 USD 		100 -3.2% 55.50 5,550 USD
2019-04-22 2019-04-18 PS Planned sale

Christmas Patrick J.

SVP, General Counsel
885 -22.2%
54.66
48,374 USD 		885 -22.2% 54.66 48,374 USD
2019-04-22 2019-04-18 PS Planned sale

Christmas Patrick J.

SVP, General Counsel
1,115 -21.8%
53.67
59,842 USD 		1,115 -21.8% 53.67 59,842 USD
2019-04-22 2019-04-18 PS Planned sale

Christmas Patrick J.

SVP, General Counsel
2,900 -36.2%
52.55
152,395 USD 		2,900 -36.2% 52.55 152,395 USD
2019-04-17 2019-04-15 PS Planned sale

Danos Olivier

Chief Scientific Officer
1,000 -13.3%
53.09
53,090 USD 		1,000 -13.3% 53.09 53,090 USD
2019-04-17 2019-04-15 PS Planned sale

Danos Olivier

Chief Scientific Officer
1,000 -11.8%
52.23
52,230 USD 		1,000 -11.8% 52.23 52,230 USD
2019-03-25 2019-03-21 PS Planned sale

Vasista Vittal

Chief Financial Officer
1,700 -0.7%
61.31
104,227 USD 		1,700 -0.7% 61.31 104,227 USD
2019-03-25 2019-03-21 PS Planned sale

Vasista Vittal

Chief Financial Officer
8,300 -3.5%
60.64
503,312 USD 		8,300 -3.5% 60.64 503,312 USD
2019-03-21 2019-03-19 PS Planned sale

Mills Kenneth T.

President and CEO
9,130 -3.6%
58.74
536,296 USD 		9,130 -3.6% 58.74 536,296 USD
2019-03-21 2019-03-19 PS Planned sale

Mills Kenneth T.

President and CEO
5,870 -2.2%
58.21
341,693 USD 		5,870 -2.2% 58.21 341,693 USD
2019-03-07 2019-03-05 PS Planned sale

Vasista Vittal

Chief Financial Officer
3,068 -1.3%
60.01
184,111 USD 		3,068 -1.3% 60.01 184,111 USD
2019-02-27 2019-02-25 PS Planned sale

Simpson Curran

SVP, Product Development & CTO
5,300 -11.8%
54.05
286,465 USD 		5,300 -11.8% 54.05 286,465 USD
2019-02-19 2019-02-15 PS Planned sale

Mills Kenneth T.

President and CEO
8,066 -3.2%
47.84
385,877 USD 		8,066 -3.2% 47.84 385,877 USD
2019-02-19 2019-02-15 PS Planned sale

Mills Kenneth T.

President and CEO
3,522 -1.4%
47.30
166,591 USD 		3,522 -1.4% 47.30 166,591 USD
2019-02-19 2019-02-15 PS Planned sale

Mills Kenneth T.

President and CEO
3,412 -1.3%
45.96
156,816 USD 		3,412 -1.3% 45.96 156,816 USD
2019-02-07 2019-02-05 PS Planned sale

Simpson Curran

SVP, Product Development & CTO
43,832 -52.6%
50.08
2,195,107 USD 		43,832 -52.6% 50.08 2,195,107 USD
2019-01-17 2019-01-15 PS Planned sale

Mills Kenneth T.

President and CEO
3,140 -1.5%
44.40
139,416 USD 		3,140 -1.5% 44.40 139,416 USD
2019-01-17 2019-01-15 PS Planned sale

Mills Kenneth T.

President and CEO
11,860 -5.5%
43.70
518,282 USD 		11,860 -5.5% 43.70 518,282 USD
2018-12-20 2018-12-18 PS Planned sale

Christmas Patrick J.

SVP, General Counsel
720 -21.2%
48.97
35,258 USD 		720 -21.2% 48.97 35,258 USD
2018-12-20 2018-12-18 PS Planned sale

Christmas Patrick J.

SVP, General Counsel
2,055 -37.7%
47.85
98,332 USD 		2,055 -37.7% 47.85 98,332 USD
2018-12-20 2018-12-18 PS Planned sale

Christmas Patrick J.

SVP, General Counsel
2,225 -29.0%
46.79
104,108 USD 		2,225 -29.0% 46.79 104,108 USD
2018-12-19 2018-12-17 PS Planned sale

Mills Kenneth T.

President and CEO
4,408 -2.0%
47.74
210,438 USD 		4,408 -2.0% 47.74 210,438 USD
2018-12-19 2018-12-17 PS Planned sale

Mills Kenneth T.

President and CEO
2,988 -1.3%
46.81
139,868 USD 		2,988 -1.3% 46.81 139,868 USD
2018-12-19 2018-12-17 PS Planned sale

Mills Kenneth T.

President and CEO
7,604 -3.3%
46.11
350,620 USD 		7,604 -3.3% 46.11 350,620 USD
2018-12-19 2018-12-17 PS Planned sale

Vasista Vittal

Chief Financial Officer
1,700 -1.4%
47.74
81,158 USD 		1,700 -1.4% 47.74 81,158 USD
2018-12-19 2018-12-17 PS Planned sale

Vasista Vittal

Chief Financial Officer
1,700 -1.4%
46.47
78,999 USD 		1,700 -1.4% 46.47 78,999 USD
2018-12-19 2018-12-17 PS Planned sale

Vasista Vittal

Chief Financial Officer
4,100 -3.2%
45.73
187,493 USD 		4,100 -3.2% 45.73 187,493 USD
2018-12-06 2018-12-03 PS Planned sale

Yoo Stephen

Chief Medical Officer
507 -100.0%
61.20
31,028 USD 		507 -100.0% 61.20 31,028 USD
2018-12-06 2018-12-03 PS Planned sale

Yoo Stephen

Chief Medical Officer
13,053 -96.3%
60.35
787,749 USD 		13,053 -96.3% 60.35 787,749 USD
2018-12-06 2018-12-03 PS Planned sale

Yoo Stephen

Chief Medical Officer
6,854 -33.6%
59.62
408,635 USD 		6,854 -33.6% 59.62 408,635 USD
2018-12-06 2018-12-03 PS Planned sale

Mills Kenneth T.

President and CEO
1,300 -0.6%
61.33
79,729 USD 		1,300 -0.6% 61.33 79,729 USD
2018-12-06 2018-12-03 PS Planned sale

Mills Kenneth T.

President and CEO
18,700 -7.5%
60.34
1,128,358 USD 		18,700 -7.5% 60.34 1,128,358 USD
2018-12-03 2018-11-29 PS Planned sale

BESHAR LUKE M

12,784 -100.0%
65.00
830,960 USD 		12,784 -100.0% 65.00 830,960 USD
2018-11-28 2018-11-27 PS Planned sale

BESHAR LUKE M

18,786 -100.0%
65.03
1,221,654 USD 		18,786 -100.0% 65.03 1,221,654 USD
2018-11-28 2018-11-26 PS Planned sale

BESHAR LUKE M

1,721 -100.0%
65.00
111,865 USD 		1,721 -100.0% 65.00 111,865 USD
2018-11-28 2018-11-26 PS Planned sale

Mills Kenneth T.

President and CEO
8,620 -3.3%
64.64
557,197 USD 		8,620 -3.3% 64.64 557,197 USD
2018-11-28 2018-11-26 PS Planned sale

Mills Kenneth T.

President and CEO
11,380 -4.2%
63.81
726,158 USD 		11,380 -4.2% 63.81 726,158 USD
2018-11-26 2018-11-21 PS Planned sale

Mills Kenneth T.

President and CEO
6,898 -2.5%
61.92
427,124 USD 		6,898 -2.5% 61.92 427,124 USD
2018-11-26 2018-11-21 PS Planned sale

Mills Kenneth T.

President and CEO
6,802 -2.4%
61.22
416,418 USD 		6,802 -2.4% 61.22 416,418 USD
2018-11-26 2018-11-21 PS Planned sale

Mills Kenneth T.

President and CEO
1,300 -0.5%
60.09
78,117 USD 		1,300 -0.5% 60.09 78,117 USD
2018-11-21 2018-11-20 PS Planned sale

BESHAR LUKE M

21,176 -100.0%
60.38
1,278,607 USD 		21,176 -100.0% 60.38 1,278,607 USD
2018-11-21 2018-11-19 PS Planned sale

Yoo Stephen

Chief Medical Officer
1,100 -100.0%
63.21
69,531 USD 		1,100 -100.0% 63.21 69,531 USD
2018-11-21 2018-11-19 PS Planned sale

Yoo Stephen

Chief Medical Officer
800 -42.1%
61.55
49,240 USD 		800 -42.1% 61.55 49,240 USD
2018-11-21 2018-11-19 PS Planned sale

Yoo Stephen

Chief Medical Officer
4,361 -69.7%
60.25
262,750 USD 		4,361 -69.7% 60.25 262,750 USD
2018-11-21 2018-11-19 PS Planned sale

Yoo Stephen

Chief Medical Officer
9,092 -59.2%
59.61
541,974 USD 		9,092 -59.2% 59.61 541,974 USD
2018-11-21 2018-11-19 PS Planned sale

Yoo Stephen

Chief Medical Officer
2,300 -13.0%
58.37
134,251 USD 		2,300 -13.0% 58.37 134,251 USD
2018-11-21 2018-11-19 PS Planned sale

Yoo Stephen

Chief Medical Officer
2,761 -13.5%
57.08
157,598 USD 		2,761 -13.5% 57.08 157,598 USD
2018-11-21 2018-11-19 PS Planned sale

BESHAR LUKE M

600 -100.0%
63.53
38,118 USD 		600 -100.0% 63.53 38,118 USD
2018-11-21 2018-11-19 PS Planned sale

BESHAR LUKE M

600 -50.0%
62.81
37,686 USD 		600 -50.0% 62.81 37,686 USD
2018-11-21 2018-11-19 PS Planned sale

BESHAR LUKE M

10,916 -90.1%
60.26
657,798 USD 		10,916 -90.1% 60.26 657,798 USD
2018-11-20 2018-11-16 PS Planned sale

Simpson Curran

SVP, Technical Operations
15,494 -28.2%
64.71
1,002,617 USD 		15,494 -28.2% 64.71 1,002,617 USD
2018-11-20 2018-11-16 PS Planned sale

Simpson Curran

SVP, Technical Operations
6,505 -10.6%
63.64
413,978 USD 		6,505 -10.6% 63.64 413,978 USD